COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity
- 23 May 2020
- journal article
- other
- Published by Elsevier BV in Revista Española de Cardiología (English Edition)
- Vol. 73 (8), 691-693
- https://doi.org/10.1016/j.rec.2020.05.009
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south XinjiangHypertension Research, 2018
- Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature reviewEuropean Heart Journal Acute Cardiovascular Care, 2012
- Association of polymorphisms of the renin–angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related coughJournal of Human Hypertension, 2002